The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of tislelizumab (TIS) and chemotherapy as neoadjuvant therapy for potentially resectable stage IIIA/IIIB non-small cell lung cancer (NSCLC).
 
Ting Wang
No Relationships to Disclose
 
Lu Li
No Relationships to Disclose
 
Lin Huang
No Relationships to Disclose
 
Jie Wei Liu
No Relationships to Disclose
 
Da Xing Zhu
No Relationships to Disclose
 
Jing Si Dong
No Relationships to Disclose
 
Han Yu Deng
No Relationships to Disclose
 
Xi Zheng
No Relationships to Disclose
 
Long Tian
No Relationships to Disclose
 
Li Li Jiang
No Relationships to Disclose
 
Wei Ya Wang
No Relationships to Disclose
 
Ping Zhou
No Relationships to Disclose
 
Ming Gang Su
No Relationships to Disclose
 
Dan Pu
No Relationships to Disclose
 
Xu Yu Cai
No Relationships to Disclose
 
Ming Yang Feng
No Relationships to Disclose
 
Xue Jin Ou
No Relationships to Disclose
 
Yongsheng Wang
No Relationships to Disclose
 
Qing Hua Zhou
No Relationships to Disclose